Cardiac allograft vasculopathy (CAV) remains a troublesome long-term complication of heart
transplantation. It is manifested by a unique and unusually accelerated form of coronary …

Several forms of pulmonary disease occur among patients treated with amiodarone, ie
chronic interstitial pneumonitis, organizing pneumonia, ARDS, a solitary pulmonary mass of …

Graft vasculopathy is an accelerated form of coronary artery disease that occurs in transplanted
hearts. Despite major advances in immunosuppression, the prevalence of the disease …

Background Current guidelines recommend potent platelet inhibition with prasugrel or ticagrelor
for 12 months after an acute coronary syndrome managed with percutaneous coronary …

Background Accelerated graft vessel disease (GVD) represents the most serious long-term
complication of heart transplantation. A possible cause underlying this progressive coronary …

Background SARS-CoV-2 entry in human cells depends on angiotensin-converting enzyme
2, which can be upregulated by inhibitors of the renin–angiotensin system (RAS). We aimed …

Background— Randomized clinical trials have demonstrated that the use of statins in heart
transplant patients lowers cholesterol levels and significantly reduces mortality and the …

Aims Little is known about the impact of treating bifurcations on the overall outcome of
multivessel coronary artery disease treated with stenting. This analysis was made to investigate …

Aims The association between air temperature and mortality has been shown to vary over
time, but evidence of temporal changes in the risk of myocardial infarction (MI) is lacking. We …

Background— Cardiac allograft vasculopathy (CAV) is initiated by allograft endothelial injury.
We hypothesized that a major mechanism by which cytomegalovirus (CMV) could …